BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1463 related articles for article (PubMed ID: 18956719)

  • 1. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
    Ma K; Wang TY; He BL; Chang D; Gong M
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
    Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?
    Doddoli C; Aragon A; Barlesi F; Chetaille B; Robitail S; Giudicelli R; Fuentes P; Thomas P
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):680-5. PubMed ID: 15784374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer.
    Izbicki JR; Passlick B; Karg O; Bloechle C; Pantel K; Knoefel WT; Thetter O
    Ann Thorac Surg; 1995 Jan; 59(1):209-14. PubMed ID: 7818326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extent of lymphadenectomy in stage I-IIIA non-small cell lung cancer: a randomized clinical trial].
    Wu Y; Wang S; Huang Z
    Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):43-5. PubMed ID: 11783068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
    Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical systematic mediastinal lymphadenectomy versus mediastinal lymph node sampling in patients with clinical stage IA and pathological stage T1 non-small cell lung cancer.
    Ma K; Chang D; He B; Gong M; Tian F; Hu X; Ji Z; Wang T
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1289-95. PubMed ID: 18504610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
    Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer.
    Okada M; Sakamoto T; Yuki T; Mimura T; Miyoshi K; Tsubota N
    Ann Thorac Surg; 2006 Mar; 81(3):1028-32. PubMed ID: 16488715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of lobe-specific mediastinal lymphadenectomy versus systematic mediastinal lymphadenectomy for clinical stage T₁a N₀ M₀ non-small cell lung cancer.
    Ma W; Zhang ZJ; Li Y; Ma GY; Zhang L
    J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S101-5. PubMed ID: 24135239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and surgical treatment for stage I non-small-cell lung cancer].
    Gao YS; Zhang DC; He J; Sun KL; Zhang DW; Zhang RG
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):52-5. PubMed ID: 15771801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.